thus elucidating the density and viability of the cell population.
For further information, consult the user manual supplied by
the manufacturer.
3. Substrate (glucose, L-alanyl-L-glutamine, L-glutamine, and L-
glutamate) and metabolite (lactate and ammonium) concentra-
tions were measured using the Cedex Bio Analyzer (Roche
Custom Biotech). The analyzer can be fitted with various test
kits, which allows the system to measure the concentration of
multiple media components simultaneously.
4. The expression of specific extracellular hMSC markers serves as
an indicator of cell quality. Thus, marker expression rates were
analyzed at the beginning, during, and upon completion of
cultivation. To determine the prevalence of these CDs,
fluorophore-conjugated primary antibodies corresponding to
the CD or antigen of interest (positive markers: CD73, CD90,
CD105, negative markers: CD36, CD45) were used in con-
junction with the MACSQuant 10 flow cytometer (Miltenyi
Biotec). The evaluation of the results was performed using the
FlowLogic software version 7.2.1 (Inivai Technologies Pty.
Ltd.).
5. An adipose-derived mesenchymal stem cell line, isolated from a
Caucasian female patient, immortalized with human telome-
rase reverse transcriptase (hTERT) (hASC52Telo or ATCC®
SCRC-4000™) and purchased from ATCC®.
6. Chemically defined culture media guarantees reproducible cul-
tivations due to the absence of animal-derived serum, proteins,
peptides, or other components. Furthermore, the use of xeno-
free media is essential for the production of cell-based thera-
pies, as it eliminates the risk of zoonotic diseases, such as bovine
spongiform encephalitis, which could potentially contaminate
the final product. To this end, the chemically defined, xeno-
and serum-free medium UrSuppe (Cardiocentro Ticino) was
used for the expansion of the hASCs, as recommended by the
manufacturer. See the publications by Jossen et al. [51] and
Panella et al. [50] for more information.
7. In order to maintain the optimal process conditions for static
cell expansion and subsequent sample work-up, both a CO2
incubator with (Minitron, Infors AG) and without (BBD
6220, Heraeus Group) an integrated orbital shaker platform
(set to 5% CO2, 130 rpm, 25 mm and 37 C) were used, while
for the spinner flask cultivations, an agitation platform (Dura-
Mag, Chemglass Life Sciences) was used in addition to the
latter.
8. The Synthemax™II-SC working solution can be prepared by
reconstituting Synthemax™II-SC Substrate (Corning®) using
sterile cell culture grade water (WFI) to produce a 1 mg mL1
Mesenchymal Stem Cell Expansion at Benchtop-Scale
105